MY141607A - Lactam compound - Google Patents

Lactam compound

Info

Publication number
MY141607A
MY141607A MYPI20015251A MYPI20015251A MY141607A MY 141607 A MY141607 A MY 141607A MY PI20015251 A MYPI20015251 A MY PI20015251A MY PI20015251 A MYPI20015251 A MY PI20015251A MY 141607 A MY141607 A MY 141607A
Authority
MY
Malaysia
Prior art keywords
lactam compound
methyl
processes
same
making
Prior art date
Application number
MYPI20015251A
Other languages
English (en)
Inventor
Thomas Mitchell Koenig
James Edmund Audia
David Mitchell
Stacey Leigh Mcdaniel
Lynne Ann Buccilli
Gary Lowell Engel
James Abraham Aikins
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MY141607A publication Critical patent/MY141607A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
MYPI20015251A 2000-11-17 2001-11-15 Lactam compound MY141607A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24965600P 2000-11-17 2000-11-17

Publications (1)

Publication Number Publication Date
MY141607A true MY141607A (en) 2010-05-31

Family

ID=22944436

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20015251A MY141607A (en) 2000-11-17 2001-11-15 Lactam compound

Country Status (33)

Country Link
US (1) US20040248878A1 (cg-RX-API-DMAC7.html)
EP (1) EP1353910B1 (cg-RX-API-DMAC7.html)
JP (1) JP4116431B2 (cg-RX-API-DMAC7.html)
KR (1) KR20030045194A (cg-RX-API-DMAC7.html)
CN (2) CN101624372A (cg-RX-API-DMAC7.html)
AR (1) AR031356A1 (cg-RX-API-DMAC7.html)
AT (1) ATE362919T1 (cg-RX-API-DMAC7.html)
AU (2) AU2432102A (cg-RX-API-DMAC7.html)
BR (1) BR0115424A (cg-RX-API-DMAC7.html)
CA (1) CA2425497C (cg-RX-API-DMAC7.html)
CY (1) CY1106682T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20031340A3 (cg-RX-API-DMAC7.html)
DE (1) DE60128587T2 (cg-RX-API-DMAC7.html)
DK (1) DK1353910T3 (cg-RX-API-DMAC7.html)
DZ (1) DZ3454A1 (cg-RX-API-DMAC7.html)
EA (1) EA006919B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP034598A (cg-RX-API-DMAC7.html)
ES (1) ES2286162T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20030385A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0301862A3 (cg-RX-API-DMAC7.html)
IL (1) IL155275A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA03004250A (cg-RX-API-DMAC7.html)
MY (1) MY141607A (cg-RX-API-DMAC7.html)
NO (1) NO325217B1 (cg-RX-API-DMAC7.html)
PE (1) PE20020798A1 (cg-RX-API-DMAC7.html)
PL (1) PL211018B1 (cg-RX-API-DMAC7.html)
PT (1) PT1353910E (cg-RX-API-DMAC7.html)
SK (1) SK287794B6 (cg-RX-API-DMAC7.html)
SV (1) SV2003000741A (cg-RX-API-DMAC7.html)
TW (1) TWI235151B (cg-RX-API-DMAC7.html)
UA (1) UA77165C2 (cg-RX-API-DMAC7.html)
WO (1) WO2002040451A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200303411B (cg-RX-API-DMAC7.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA74849C2 (en) * 2000-11-17 2006-02-15 Lilly Co Eli Lactam
TWI323256B (en) 2002-12-20 2010-04-11 Glaxo Group Ltd Novel benzazepine derivatives and pharmaceutical compositions comprising said compounds
CN102558155A (zh) 2003-01-14 2012-07-11 阿伦纳药品公司 作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
RU2404968C2 (ru) 2005-04-08 2010-11-27 Дайити Санкио Компани, Лимитед Пиридилдиметилсульфоновое производное
US8258302B2 (en) 2006-01-31 2012-09-04 Api Corporation Method for producing benzazepinone
TW200920362A (en) 2007-09-11 2009-05-16 Daiichi Sankyo Co Ltd Alkylsulfone derivatives
FR2932800B1 (fr) * 2008-06-20 2015-02-20 Servier Lab Nouveau procede de synthese de la 7,8-dimethoxy-1,3-dihydro- 2h-3-benzazepin-2-one, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
BR112013008100A2 (pt) 2010-09-22 2016-08-09 Arena Pharm Inc "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles."
KR101899014B1 (ko) 2012-01-06 2018-09-17 삼성전자주식회사 비엘디씨 모터의 제어 장치 및 그 방법
CN102690231B (zh) * 2012-04-11 2014-07-09 南京友杰医药科技有限公司 治疗阿尔茨海默病潜在药物司马西特的合成方法
EP2987496B1 (en) 2013-04-19 2018-08-08 National University Corporation Okayama University Treatment agent for cognitive disorders, induced by amyloid -protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these
EP3242666B9 (en) 2015-01-06 2024-12-25 Arena Pharmaceuticals, Inc. Compound for use in treating conditions related to the s1p1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
MX2019009841A (es) 2017-02-16 2020-01-30 Arena Pharm Inc Compuestos y metodos para el tratamiento de la colangitis biliar primaria.
KR102859841B1 (ko) 2018-06-06 2025-09-12 아레나 파마슈티칼스, 인크. S1p1 수용체와 관련된 병태의 치료 방법
KR20230005163A (ko) 2020-03-26 2023-01-09 씨젠 인크. 다발성 골수종 치료 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158355A0 (en) * 1996-12-23 2004-05-12 Elan Pharm Inc CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS beta-AMYLOID PEPTIDE RELEASE INHIBITORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
JP2002518481A (ja) * 1998-06-22 2002-06-25 エラン ファーマシューティカルズ，インコーポレイテッド β−アミロイドペプチドの放出および／またはその合成を阻害するための化合物
CA2390376A1 (en) * 1999-11-09 2001-05-17 William Leonard Scott .beta.-aminoacid compounds useful for inhibiting .beta.-amyloid peptide release and/or its synthesis

Also Published As

Publication number Publication date
DZ3454A1 (fr) 2002-05-23
AR031356A1 (es) 2003-09-17
AU2002224321B2 (en) 2006-10-19
HUP0301862A3 (en) 2007-09-28
CY1106682T1 (el) 2012-05-23
JP4116431B2 (ja) 2008-07-09
IL155275A0 (en) 2003-11-23
NO20032215L (no) 2003-07-16
PL360991A1 (en) 2004-09-20
ZA200303411B (en) 2004-08-02
CA2425497A1 (en) 2002-05-23
NO325217B1 (no) 2008-02-25
MXPA03004250A (es) 2003-09-22
NO20032215D0 (no) 2003-05-15
EP1353910B1 (en) 2007-05-23
JP2004521084A (ja) 2004-07-15
CN1575282A (zh) 2005-02-02
SK5432003A3 (en) 2004-09-08
DK1353910T3 (da) 2007-09-10
PL211018B1 (pl) 2012-03-30
DE60128587T2 (de) 2008-01-31
HUP0301862A2 (hu) 2003-09-29
PE20020798A1 (es) 2002-09-06
WO2002040451A3 (en) 2003-08-28
AU2432102A (en) 2002-05-27
SV2003000741A (es) 2003-01-13
TWI235151B (en) 2005-07-01
EA200300579A1 (ru) 2003-12-25
WO2002040451A2 (en) 2002-05-23
BR0115424A (pt) 2003-10-21
EP1353910A2 (en) 2003-10-22
CZ20031340A3 (cs) 2004-06-16
HRP20030385A2 (en) 2003-08-31
EA006919B1 (ru) 2006-04-28
PT1353910E (pt) 2007-08-20
CA2425497C (en) 2010-08-17
ATE362919T1 (de) 2007-06-15
US20040248878A1 (en) 2004-12-09
SK287794B6 (sk) 2011-10-04
KR20030045194A (ko) 2003-06-09
DE60128587D1 (de) 2007-07-05
UA77165C2 (en) 2006-11-15
ES2286162T3 (es) 2007-12-01
CN101624372A (zh) 2010-01-13
CN100516047C (zh) 2009-07-22
ECSP034598A (es) 2003-06-25

Similar Documents

Publication Publication Date Title
MY134559A (en) Lactam compound to inhibit beta-amyloid peptide release or synthesis
MY141607A (en) Lactam compound
WO1999064047A8 (en) Novel antiviral compounds
MXPA03009087A (es) Estuches para blanquear los dientes.
AU2002224893A1 (en) Method for producing a part and device for carrying out this method
MY139523A (en) Ziprasidone composition and synthetic controls
MXPA04004939A (es) 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
MXPA03007693A (es) Composicion para la piel.
ZA200205875B (en) Method for providing improved polymeric composition.
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
YU18801A (sh) Eletriptan hidrobromid monohidrat
EG23378A (en) Composition.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
AU2002224322A1 (en) Lactam dipeptide and its use in inhibiting beta-amyloid peptiderelease
MXPA03008077A (es) Composicion humedecedora para la piel..
ID27733A (id) Metoksiminofenilasetamida
CA2328832A1 (en) Processes for preparing pesticidal intermediates
ITBO980664A0 (it) Composizione , procedimento e apparecchiatura per la lucidatura di pez zi .
CA2420056A1 (en) 1-amino-alkylcyclohexanes as trypanocidal agents
MXPA03007242A (es) Delta-1-pirrolinas para control de pestes.
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
MXPA02007005A (es) Pseudopolimorfo de (-) -cis-2 -(2-clorofenil) -5, 7-dihidorxi -8[4r-(3s-hidroxi -1-meitl) piperidinil] -4h-1-benzopiran -4-ona.
PL347673A1 (en) 1,4-diaryl-2-fluoro-1-buten-3-ol compounds and their use in the preparation of 1,4-diaryl-2-fluoro-1,3-butadiene and 1,4-diaryl-2-fluoro-2-butene compounds
AU2001270741A1 (en) Steel compositions, method for obtaining same and parts made from same